Unknown

Dataset Information

0

Integrin-?4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells.


ABSTRACT: Neoplastic cells within individual carcinomas often exhibit considerable phenotypic heterogeneity in their epithelial versus mesenchymal-like cell states. Because carcinoma cells with mesenchymal features are often more resistant to therapy and may serve as a source of relapse, we sought to determine whether such cells could be further stratified into functionally distinct subtypes. Indeed, we find that a basal epithelial marker, integrin-?4 (ITGB4), can be used to enable stratification of mesenchymal-like triple-negative breast cancer (TNBC) cells that differ from one another in their relative tumorigenic abilities. Notably, we demonstrate that ITGB4+ cancer stem cell (CSC)-enriched mesenchymal cells reside in an intermediate epithelial/mesenchymal phenotypic state. Among patients with TNBC who received chemotherapy, elevated ITGB4 expression was associated with a worse 5-year probability of relapse-free survival. Mechanistically, we find that the ZEB1 (zinc finger E-box binding homeobox 1) transcription factor activity in highly mesenchymal SUM159 TNBC cells can repress expression of the epithelial transcription factor TAp63? (tumor protein 63 isoform 1), a protein that promotes ITGB4 expression. In addition, we demonstrate that ZEB1 and ITGB4 are important in modulating the histopathological phenotypes of tumors derived from mesenchymal TNBC cells. Hence, mesenchymal carcinoma cell populations are internally heterogeneous, and ITGB4 is a mechanistically driven prognostic biomarker that can be used to identify the more aggressive subtypes of mesenchymal carcinoma cells in TNBC. The ability to rapidly isolate and mechanistically interrogate the CSC-enriched, partially mesenchymal carcinoma cells should further enable identification of novel therapeutic opportunities to improve the prognosis for high-risk patients with TNBC.

SUBMITTER: Bierie B 

PROVIDER: S-EPMC5373369 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Integrin-β4 identifies cancer stem cell-enriched populations of partially mesenchymal carcinoma cells.

Bierie Brian B   Pierce Sarah E SE   Kroeger Cornelia C   Stover Daniel G DG   Pattabiraman Diwakar R DR   Thiru Prathapan P   Liu Donaher Joana J   Reinhardt Ferenc F   Chaffer Christine L CL   Keckesova Zuzana Z   Weinberg Robert A RA  

Proceedings of the National Academy of Sciences of the United States of America 20170307 12


Neoplastic cells within individual carcinomas often exhibit considerable phenotypic heterogeneity in their epithelial versus mesenchymal-like cell states. Because carcinoma cells with mesenchymal features are often more resistant to therapy and may serve as a source of relapse, we sought to determine whether such cells could be further stratified into functionally distinct subtypes. Indeed, we find that a basal epithelial marker, integrin-β4 (ITGB4), can be used to enable stratification of mesen  ...[more]

Similar Datasets

2017-03-06 | GSE95540 | GEO
| S-EPMC7275473 | biostudies-literature
| S-EPMC5233967 | biostudies-literature
| S-EPMC4737105 | biostudies-literature
| S-EPMC6344979 | biostudies-literature
| S-EPMC6541606 | biostudies-literature
| S-EPMC5361192 | biostudies-literature
| S-EPMC6339386 | biostudies-literature
| S-EPMC3735517 | biostudies-literature
| S-EPMC4333504 | biostudies-other